Keywords: gene, therapy, angina, clears, ph, ii, trial

Gene therapy for angina clears Ph II trial

Article | 18 March 2002

Print This

The results of a Phase II study have shown that a gene therapy,developed by Schering AG subsidiary Berlex Laboratories ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in